Advanced Biomed INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Advanced Biomed Inc. has filed its proxy statement for the Annual Meeting of Stockholders on June 30, 2026, detailing proposals including director elections, executive compensation votes, and auditor ratification.
NASDAQ
Advanced Biomed Inc. announces a planned reverse stock split, ranging from 1:2 to 1:100, to maintain its listing on The Nasdaq Capital Market.